Applications published 13 July 2011
Selected patent applications from the weekly European Patents Bulletin
- Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
Paratek Pharmaceuticals 2341771*
- Synthesis of decitabine
ScinoPharm Taiwan 2341772*
- Pharmaceutical compsns of atorvastatin
Merck Sharp & Dohme 2341773*
- Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
Enzon Pharmaceuticals 2341774*
- Inhibitors of janus kinases
Merck 2341775*
- Compounds, compsns and methods comprising imidazole and triazole derivatives
Institute for OneWorld Health 2341776*
- Antimicrobial oxazolidinone, hydantoin and imidazolidinone compsns
NovaBay Pharmaceuticals 2341777*
- Pharmaceutical compsn
R-Tech Ueno 2341894*
- Hyaluronic acid cryogel – compsns, uses, processes for manufacturing
Burdica Biomed 2341895*
- Lipid pellets with enhanced taste-masking
Breitkreutz Jörg 2341896*
- Nanoparticles for immunotherapy
Ecole Polytechnique Fédérale de Lausanne 2341897*
- Stable solid formulations of GC0-C receptor agonist polypeptides suitable for oral administration
Ironwood Pharmaceuticals 2341898*
- pH-dependent controlled release pharmaceutical opioid compsn with resistance against the influence of ethanol
Evonik Röhm 2341899*
- A medicinal product and treatment
AFT Pharmaceuticals 2341900*
- A polysaccharide capsule enclosing a fatty acid oil-containing emulsion
Pronova BioPharma Norge 2341901*
- Glucoside derivatives and uses thereof as SGLT inhibitors
Novartis 2341902*
- Cannabinoids for use in treating cognitive impairment and dementia
Bionorica Research 2341903*
- Methods for treatment of multiple sclerosis
Fibrogen 2341904*
- Sustained release formulations using non-aqueous carriers
Amylin Pharmaceuticals 2341905*
- Haematopoietic protection against ionising radiation using selective cyclin-dependent kinase 4/6 inhibitors
The Univ. of North Carolina at Chapel Hill 2341906*
- Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
Ortho-McNeil-Janssen Pharmaceuticals 2341907*
- Individual 5-fluorouracile dose optimisation in folfiri treatment
Centre Regional de Lutte Contre le Cancer d-Angers; Universite d’Angers 2341908*
- Nocel substituted azabenzoxazoles
Merck Sharp & Dohme 2341909*
- Immediate release dosage forms of sodium oxybate
Jazz Pharmaceuticals 2341910*
- Haematopoietic protection against chemotherapeutic compounds using cyclin-dependent kinase 4/6 inhibitors
The University of North Carolina at Chapel Hill 2341911*
- Method of treatment of attention deficit/hyperactivity disorder (ADHD)
Supernus Pharmaceuticals 2341912*
- Method of enhancing TGF-beta signalling
Saint Louis University; Auxagen 2341913*
- Modulation of toll-like receptor 3 expression by antisense oligonucleotides
Idera Pharmaceuticals 2341914*
- Phosphorylated dendrimers as antiinflammatory drugs
Centre National de la Recherche Scientifique; Institut National e la Santé et de la Recherche Medicale 2341915*
- Colostrum compsn
Nanoko 2341916*
- A topical compsn comprising extracts of A. indica and M. charantia or S. indicum
Unilever 2341917*
- Herbal formulations
Life Biotech Medical Research 2341918*
- CGRP receptor antagonists
Merck Sharp & Dohme 2341919*
- Antimicrobial peptides
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt 2341920*
- Antimicrobial peptides
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt 2341921*
- Complement proteins
The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin 2341922*
- Pharmaceutical compsn comprising coenzyme Q10
Sharma, Saumya’ Thakur, Srinath; Setty, Swati; Kulkarni, Rajesh; Kulkarni, Shirishkumar 2341923*
- Methods of treating hepatitis C virus infection
The J David Gladstone Institutes 2341924*
- Compsn of thrombolytic agent and antithrombosis and also its production method
Pt Dexa Medica 2341925*
- Method for purifying protein complexes
Immunobiology 2341926*
- Novel immunotherapy against several tumours including neuronal and brain tumours
Immatics Biotechnologies 2341927*
- Mycobacterium tuberculosis vaccine
University of Zürich 2341928*
- Compsns and methods related to bacterial EAP, EMP, and/or ADSA proteins
University of Chicago 2341929*
- Outer membrane vesicle prime-protein boost vaccine
Health Protection Agency 2341930*
- Vaccine compsn for use against influenza
Wittycell; Serra, Vincent 2341931*
- High-energy pulsed electric field vaccine adjuvants
OOO “Npt Mpb Gormezis” 2341932*
- Lipidated imidazoquinoline derivatives
GlaxoSmithKline Biologicals 2341933*
- Methods to reduce B-helper T-cells to treat autoimmune diseases
Baylor Research Institute 2341934*
- Methods for improvement of beta cell function
XOMA Technology 2341935*
- Methods for treating or preventing IL-1beta related diseases
XOMA Technology 2341936*
- Compsn for treating disease
Biotest 2341937*
- Use of an ANG-(1-7) receptor agonist in acute lung injury
Charité - Universitätsmedizin Berlin 2341938*